logo
logo
AI Products 

Preterm Birth And Prom Testing Market Is Anticipated To Witness Steady Growth Owing To Increase In Preterm Birth Cases

avatar
Akanksha Gaikwad
Preterm Birth And Prom Testing Market Is Anticipated To Witness Steady Growth Owing To Increase In Preterm Birth Cases

The preterm birth and prom testing market offers various diagnostic tests to detect complications related to preterm birth. Preterm birth can cause serious health issues in newborns including respiratory problems,feeding difficulties, cerebral palsy, and vision and hearing loss. Hence, early detection and diagnosis of preterm labor is crucial. Prom testing assesses proteins that are biomarkers for predicting the risk of preterm birth before signs and symptoms occur. The Global preterm birth and prom testing market is estimated to be valued at US$ 1.95 Mn in 2024 and is expected to exhibit a CAGR of 4.7% over the forecast period 2024 to 2031.

Key Takeaways

Key players operating in the preterm birth and prom testing market are Sanofi S.A., AbbVie Inc., Perrigo Company PLC, 3M, Lee's Pharmaceutical Holdings Ltd, Cassiopea, Glenmark Pharmaceuticals, Bausch Health, and Novartis International AG. These players are focusing on new product launches and geographic expansion strategies to strengthen their market position.

The rising awareness regarding adverse consequences of preterm birth and availability of various diagnostic tests provide significant growth opportunities in the market. Moreover, growing health expenditures and insurance coverage for maternal healthcare are prompting more women to opt for preterm birth screening.

The key players are expanding their presence globally, especially in emerging markets of Asia Pacific and Latin America. These regions witnessing increasing patient pool due to growing preterm birth incidents and rising healthcare investments by various governments.

Market Drivers

Increasing incidence of preterm birth worldwide is a major factor fueling the market growth. According to WHO, preterm birth complications are the leading cause of death among children under 5 years of age. Around 15 million babies are born preterm each year. The rising maternal stress levels, obesity, smoking, and infertility treatments are contributing to the rising preterm birth prevalence.


The growing awareness about benefits of early detection and diagnosis of preterm labor is another key driver. It allows physicians to monitor the condition closely and enables timely intervention to prevent delivery before 37 weeks of gestation. Various government and non-profit organization initiatives to educate women about preterm birth testing boost the market expansion.


Market Restraints

High cost of advanced diagnostic tests for preterm birth acts as a significant restraint. Many women in low-income countries cannot afford the expensive tests, hampering the market growth. Moreover, lack of reimbursement policies for preterm birth screening in some emerging nations also hinders the market growth. Unclear regulatory guidelines for new diagnostic procedures pose another challenge for market players.

Segment Analysis

There are various sub-segments in the Preterm birth and PROM testing market. The key sub-segments are:


- Prenatal corticosteroid administration: This treatment is administered to women who are at risk of preterm birth to reduce complications in newborns. It is the most dominating sub-segment as its usage has significantly reduced neonatal mortality and morbidity.

- Preterm birth diagnosis testing kit: This involves various diagnostic tests like fetal fibronectin test, interleukin tests, ultrasound for cervical length screening. These help detect women at risk before actual preterm birth. The fetal fibronectin test segment is the largest as it provides an early and accurate prediction of preterm birth.

- Tocolysis drugs: These drugs are used to slow down or stop labor contractions and delay delivery for a short period. Beta-mimetics like terbutaline sulfate is most commonly administered as it is effective tocolytic agent.

Global Analysis

North America region currently holds the largest market share due to advanced healthcare facilities, availability of skilled professionals, and awareness regarding adverse effects of preterm births. However, Asia Pacific is expected to grow at the fastest pace during the forecast period owing to improving healthcare infrastructure, increasing fertility rates, and elevated incidence of preterm births in developing countries like India and China. Initiatives by governments and NGOs regarding maternal and newborn care supplements market growth in the region.

collect
0
avatar
Akanksha Gaikwad
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more